BSI-709

N/A

Report date: 2024/11/13 15:02:29

Base Information

Drug NameBSI-709
Drug Alias NameBSI-709
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionCadherin-6 modulators
TargetsCadherin-6
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiosion IncImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosion IncImmunogen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A